Senator Durazo's menstrual product safety legislation establishes new chemical monitoring requirements for manufacturers of disposable tampons and pads, requiring them to maintain concentration data for lead, arsenic, cadmium, and zinc starting December 31, 2026.
The Department of Toxic Substances Control receives authority to identify additional chemicals of concern based on two criteria: detection in menstrual products and evidence of adverse public health impacts. The department may publish approved testing methods and laboratory accreditation requirements, while maintaining discretion to update these protocols. Manufacturers must provide technical documentation and test results upon request, with the department authorized to conduct independent verification testing at manufacturer expense.
The legislation creates a public disclosure framework through which the department may publish analytical results and related health impact information in a searchable online format. Testing fees and other charges collected from manufacturers will be deposited in the existing T.A.M.P.O.N. Act Fund, available upon legislative appropriation to support the department's implementation and oversight activities. This builds upon current state law prohibiting certain perfluoroalkyl and polyfluoroalkyl substances in menstrual products.
![]() Maria DurazoD Senator | Bill Author | Not Contacted |
Email the authors or create an email template to send to all relevant legislators.
Senator Durazo's menstrual product safety legislation establishes new chemical monitoring requirements for manufacturers of disposable tampons and pads, requiring them to maintain concentration data for lead, arsenic, cadmium, and zinc starting December 31, 2026.
The Department of Toxic Substances Control receives authority to identify additional chemicals of concern based on two criteria: detection in menstrual products and evidence of adverse public health impacts. The department may publish approved testing methods and laboratory accreditation requirements, while maintaining discretion to update these protocols. Manufacturers must provide technical documentation and test results upon request, with the department authorized to conduct independent verification testing at manufacturer expense.
The legislation creates a public disclosure framework through which the department may publish analytical results and related health impact information in a searchable online format. Testing fees and other charges collected from manufacturers will be deposited in the existing T.A.M.P.O.N. Act Fund, available upon legislative appropriation to support the department's implementation and oversight activities. This builds upon current state law prohibiting certain perfluoroalkyl and polyfluoroalkyl substances in menstrual products.
Ayes | Noes | NVR | Total | Result |
---|---|---|---|---|
40 | 0 | 0 | 40 | PASS |
![]() Maria DurazoD Senator | Bill Author | Not Contacted |